Frigg Arno, Pagenstert Geert, Schäfer Dirk, Valderrabano Victor, Hintermann Beat
Department of Orthopaedic Surgery, University Hospital of Basel, Spitalstrasse 21, Basel, CH-4031, Switzerland.
Foot Ankle Int. 2007 Jan;28(1):64-9. doi: 10.3113/FAI.2007.0012.
Total contact casting (TCC) has become established as standard treatment for Wagner grades 1 and 2 diabetic foot ulcers. However, the recurrence rate after TCC is unacceptably high, and a clear concept to prevent recurrences is still lacking. The purpose of this study was to evaluate recurrences and the effectiveness of preventive measures in a group of diabetic patients treated with TCC.
From January of 1999, to June of 2004, 28 patients (20 men and 8 women; average age 63 years) with 34 ulcers were treated using TCC. Thereafter, orthopaedic shoes were provided and patients were followed regularly. Recurrences were treated first by TCC, and operative correction was carried out in patients with an underlying foot deformity. Mean followup was 2.8 (1 to 5) years.
Primary TCC treatment lasted 4 (1 to 17) months. Complete healing was achieved in 85% of ulcers; 57% of patients had a total of 26 recurrences, and 18 new ulcers were found in a different area or on the other foot. Sixteen recurrences were treated successfully by TCC, but the rate of new recurrences during followup was 50%. Eight recurrences were treated by operative correction of foot deformities. Most patients stayed ulcer-free thereafter. An unloading shoe was applied twice. No amputations were required.
The first TCC showed an effective healing rate of 85%. The high recurrence rate of 57% in the presence of optimal instruction, shoes, and followup suggests that these measures are not sufficient. However, because patients who had operative corrections stayed ulcer-free thereafter, it is suggested that foot deformities should be operatively corrected immediately after primary healing rather than waiting until further recurrences occur.
全接触石膏固定(TCC)已成为Wagner 1级和2级糖尿病足溃疡的标准治疗方法。然而,TCC后的复发率高得令人难以接受,且仍缺乏预防复发的明确概念。本研究的目的是评估一组接受TCC治疗的糖尿病患者的复发情况及预防措施的有效性。
1999年1月至2004年6月,对28例患者(20例男性,8例女性;平均年龄63岁)的34处溃疡采用TCC治疗。此后,为患者提供矫形鞋并定期随访。复发时首先采用TCC治疗,对存在足部畸形的患者进行手术矫正。平均随访时间为2.8(1至5)年。
初次TCC治疗持续4(1至17)个月。85%的溃疡实现完全愈合;57%的患者共出现26处复发,且在不同部位或另一只脚上发现18处新溃疡。16处复发通过TCC成功治疗,但随访期间新复发率为50%。8处复发通过足部畸形手术矫正治疗。此后大多数患者保持无溃疡状态。使用了两次减负鞋。无需截肢。
初次TCC显示有效愈合率为85%。在有最佳指导、鞋子和随访的情况下,57%的高复发率表明这些措施并不充分。然而,由于接受手术矫正的患者此后保持无溃疡状态,建议在初次愈合后立即对足部畸形进行手术矫正,而不是等到进一步复发时。